查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1475911

骨髓移植市場：依地區：全球產業分析、規模、佔有率、成長、趨勢、預測，2024-2031年

Bone Marrow Transplantation Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 190 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

該研究報告對全球骨髓移植市場進行了全面分析，深入瞭解了市場趨勢、成長動力、課題和新興機會。這份研究報告對市場進行了深入研究，重點關注揭示 2024 年至 2031 年市場軌蹟的關鍵統計數據和預測。

重要見解

  • 骨髓移植市場規模（2024年）：111.37億美元
  • 市場預測（2031年）：143.36億美元
  • 全球市場成長率（2024-2031年複合年增長率）：3.67%

骨髓移植市場 - 報告範圍：

骨髓移植市場包括治療各種血液疾病、實體腫瘤和自體免疫疾病所必需的程序和技術。這些包括同種異體移植、自體移植、造血幹細胞收穫、預處理方案和支持性治療。該市場為醫院、移植中心和專科診所提供服務，提供先進的移植解決方案，以改善患者的治療效果和生活品質。

市場成長動力：

全球骨髓移植市場由多種成長因素推動。血液系統惡性腫瘤和自體免疫疾病的盛行率不斷增加，加上移植技術和支持治療的進步，正在推動骨髓移植手術的需求。移植物處理、免疫抑制治療和移植物抗宿主疾病 (GVHD) 預防方面的創新正在提高移植成功率，並將移植資格擴大到更廣泛的患者群體。此外，移植中心、研究機構和製藥公司之間的合作正在加速臨床研究並促進新型移植療法的創新和採用。

市場限制因素：

儘管骨髓移植市場預計將顯著成長，但仍面臨與手術併發症、移植相關發生率和醫療基礎設施限制相關的課題。移植的高昂費用，加上移植物排斥、感染和 GVHD 的風險，給患者和醫療保健系統帶來了經濟和臨床負擔，限制了移植服務的廣泛普及。此外，捐贈者可用性、HLA 匹配和移植後護理方面的差異也會導致移植結果和患者存活率的差異，因此需要全面的患者評估和個別化治療方法。

市場機會：

在細胞療法、再生醫學和免疫療法進步的推動下，骨髓移植市場提供了充滿希望的機會。單倍體移植、離體移植操作和嵌合抗原受體 (CAR) T 細胞療法等新興趨勢正在徹底改變移植策略，並為難治性疾病和復發性惡性腫瘤患者提供治療選擇。此外，對精準醫學、基因組學和生物標記發現的投資將有助於患者選擇、治療優化和長期監測，從而提高移植療效並減少與治療相關的毒性。此外，移植中心、生物技術公司和監管機構之間的策略合作夥伴關係將加速下一代移植產品和治療的創新和監管審批。

本報告解決的關鍵問題

  • 推動全球骨髓移植市場成長的關鍵因素是什麼？
  • 技術進步和臨床研究如何影響移植技術和支持性治療的發展？
  • 骨髓移植領域的市場參與者面臨哪些主要課題與機會？
  • 骨髓移植服務成長潛力最大的地區和醫療機構在哪裡？
  • 在骨髓移植的競爭格局中，領先公司採取哪些策略來提高產品創新、市場滲透和臨床效果？

目錄

第一章執行摘要

第二章 市值與預測對比

第 3 章市場概況

  • 市場範圍/分類
  • 市場定義/範圍/限制

第 4 章主要市場趨勢

第五章 關鍵成功因素

第六章 全球骨髓移植市場分析（金額）

  • 過去的市場（金額）分析，2019-2023
  • 當前和未來市場（價值）預測，2024-2031

第七章市場背景

  • 宏觀經濟因素
  • 預測變量 - 相關性和影響
  • 市場動態

第 8 章依移植類型劃分的全球骨髓移植市場分析

  • 簡介/主要發現
  • 過去的市場規模（金額）分析，2019-2023
  • 當前和未來市場規模（金額）分析和預測，2024-2031
    • 自體骨髓移植
    • 同種異體骨髓移植
  • 依移植類型的市場吸引力分析

第九章全球骨髓移植市場適應症分析

  • 簡介/主要發現
  • 過去的市場規模（金額）分析，2019-2023
  • 當前和未來市場規模（金額）分析和預測，2024-2031
    • 白血病
    • 淋巴瘤
    • 骨髓瘤
    • 骨髓增生異常
    • 骨髓增生性腫瘤
    • 再生障礙性貧血
    • 實體腫瘤
    • 鐮狀細胞性貧血
    • 地中海型貧血
    • 其他
  • 依症狀進行市場吸引力分析

第 10 章全球骨髓移植市場分析（依最終用戶）

  • 簡介/主要發現
  • 過去的市場規模（金額）分析，2019-2023
  • 當前和未來市場規模（金額）分析和預測，2024-2031
    • 醫院
    • 多學科診所
    • 門診手術中心
  • 最終用戶的市場吸引力分析

第十一章全球骨髓移植市場分析（依地區）

  • 介紹
  • 過去的市場規模（金額）分析，2019-2023
  • 當前市場規模（金額）分析與預測，2024-2031
    • 北美
    • 拉丁美洲
    • 歐洲
    • 東亞
    • 南亞
    • 大洋洲
    • 中東和非洲 (MEA)
  • 區域市場吸引力分析

第十二章北美骨髓移植市場分析

第十三章拉丁美洲骨髓移植市場分析

第十四章歐洲骨髓移植市場分析

第十五章南亞骨髓移植市場分析

第十六章東亞骨髓移植市場分析

第十七章大洋洲骨髓移植市場分析

第十八章中東與非洲骨髓移植市場分析

第 19 章 競爭分析

  • 比賽儀表板
  • 衝突詳情
    • Lonza Group Ltd.
    • Merck Millipore Corporation
    • Sanofi-Aventis LLC.
    • STEMCELL Technologies.
    • American Type Culture Collection（ATCC）Inc
    • ReeLabs Pvt. Ltd.
    • HemaCare

第 20 章使用的假設和首字母縮略詞

第21章研究方法論

簡介目錄
Product Code: PMRREP4288

Persistence Market Research presents a comprehensive analysis of the global Bone Marrow Transplantation Market, offering insights into market trends, growth drivers, challenges, and emerging opportunities. This study provides a detailed examination of the market, highlighting crucial statistics and projections that delineate the market's trajectory from 2024 to 2031.

Key Insights:

  • Bone Marrow Transplantation Market Size (2024): USD 11,137 Million
  • Projected Market Value (2031): USD 14,336 Million
  • Global Market Growth Rate (CAGR 2024 to 2031): 3.67%

Bone Marrow Transplantation Market - Report Scope:

The Bone Marrow Transplantation Market encompasses procedures and technologies vital for treating various hematological disorders, solid tumors, and autoimmune diseases. These include allogeneic and autologous transplantations, hematopoietic stem cell collection, conditioning regimens, and supportive care measures. The market caters to hospitals, transplant centers, and specialty clinics, providing advanced transplantation solutions to improve patient outcomes and quality of life.

Market Growth Drivers:

The global Bone Marrow Transplantation Market is propelled by several growth factors. The increasing prevalence of hematological malignancies and autoimmune disorders, coupled with advancements in transplant techniques and supportive care, drive demand for bone marrow transplantation procedures. Technological innovations in graft processing, immunosuppressive therapies, and graft-versus-host disease (GVHD) prophylaxis enhance transplant success rates and expand the applicability of transplantation across a broader patient population. Additionally, collaborative efforts between transplant centers, research institutions, and pharmaceutical companies accelerate clinical research, driving innovation and adoption of novel transplantation therapies.

Market Restraints:

Despite significant growth prospects, the Bone Marrow Transplantation Market faces challenges related to procedural complications, transplant-related morbidities, and healthcare infrastructure limitations. The high cost of transplantation, coupled with the risk of graft rejection, infection, and GVHD, poses financial and clinical burdens on patients and healthcare systems, limiting widespread access to transplantation services. Moreover, disparities in donor availability, HLA matching, and post-transplant care contribute to variations in transplant outcomes and patient survival rates, underscoring the need for comprehensive patient evaluation and personalized treatment approaches.

Market Opportunities:

The Bone Marrow Transplantation Market presents promising opportunities driven by advances in cellular therapy, regenerative medicine, and immunotherapy. Emerging trends such as haploidentical transplantation, ex vivo graft manipulation, and chimeric antigen receptor (CAR) T-cell therapy revolutionize transplant strategies, offering curative options for patients with refractory diseases and relapsed malignancies. Furthermore, investments in precision medicine, genomics, and biomarker discovery facilitate patient selection, treatment optimization, and long-term monitoring, thereby improving transplant efficacy and reducing treatment-related toxicities. Additionally, strategic collaborations between transplant centers, biotechnology firms, and regulatory agencies foster innovation and regulatory approval for next-generation transplantation products and therapies.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Bone Marrow Transplantation Market globally?
  • How are technological advancements and clinical research shaping the evolution of transplantation techniques and supportive care measures?
  • What are the key challenges and opportunities facing market participants in the field of bone marrow transplantation?
  • Which geographic regions and healthcare settings offer the highest growth potential for bone marrow transplantation services?
  • What strategies are leading companies employing to enhance product innovation, market penetration, and clinical outcomes in the competitive landscape of bone marrow transplantation?

Competitive Intelligence and Business Strategy:

Leading players in the global Bone Marrow Transplantation Market, including transplant centers, biopharmaceutical companies, and research organizations, focus on innovation, clinical evidence generation, and market expansion to maintain a competitive edge. These entities invest in research and development to develop novel transplantation techniques, graft engineering strategies, and immunomodulatory therapies aligned with clinical guidelines and patient needs. Moreover, strategic partnerships with academic institutions, patient advocacy groups, and government agencies facilitate collaborative research, clinical trial enrollment, and regulatory approval for transplantation products and therapies. Furthermore, emphasis on post-transplant surveillance, long-term follow-up, and patient-reported outcomes ensures optimal transplant outcomes and patient satisfaction in the dynamic landscape of bone marrow transplantation.

Key Companies Profiled:

  • National Marrow Donor Program
  • DKMS
  • Be The Match
  • Lonza Group
  • Regen Biopharma Inc.
  • Celgene Corporation
  • Novartis AG
  • Takeda Pharmaceutical Company Limited
  • Sanofi
  • Pfizer Inc.
  • Others.

Bone Marrow Transplantation Market Segmentation:

By End User

  • Hospitals
  • Multispecialty Clinics
  • Ambulatory Surgical Centers

By Transplant Type

  • Autologous Bone Marrow Transplant
  • Allogeneic Bone marrow Transplant

By Disease Indication

  • Leukemia
  • Lymphoma
  • Myeloma
  • Others

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa (MEA)

Table of Contents

1. Executive Summary

2. Market Value and Forecast Comparison

3. Market Overview

  • 3.1. Market Coverage / Taxonomy
  • 3.2. Market Definition / Scope / Limitations

4. Key Market Trends

5. Key Success Factors

6. Global Bone Marrow Transplantation Market Value Analysis 2019-2023 and Forecast, 2024-2031

  • 6.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 6.2. Current and Future Market Value (US$ Mn) Projections, 2024-2031
    • 6.2.1. Y-o-Y Growth Trend Analysis
    • 6.2.2. Absolute $ Opportunity Analysis

7. Market Background

  • 7.1. Macro-Economic Factors
    • 7.1.1. Increasing per capita healthcare expenditure
    • 7.1.2. Changes in economic structure and employment
  • 7.2. Forecast Factors - Relevance & Impact
  • 7.3. Market Dynamics
    • 7.3.1. Drivers
    • 7.3.2. Restraints
    • 7.3.3. Opportunity Analysis

8. Global Bone Marrow Transplantation Market Analysis 2019-2023 and Forecast 2024-2031, by Transplantation Type

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis By Transplantation Type, 2019-2023
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Transplantation Type, 2024-2031
    • 8.3.1. Autologous Bone Marrow Transplant
    • 8.3.2. Allogeneic Bone Marrow Transplant
  • 8.4. Market Attractiveness Analysis By Transplantation Type

9. Global Bone Marrow Transplantation Market Analysis 2019-2023 and Forecast 2024-2031, by Indication

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis By Indication, 2019-2023
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2024-2031
    • 9.3.1. Leukemia
    • 9.3.2. Lymphoma
    • 9.3.3. Myeloma
    • 9.3.4. Myelodysplasia
    • 9.3.5. Myeloproliferative Neoplasms
    • 9.3.6. Aplastic Anemia
    • 9.3.7. Solid tumors
    • 9.3.8. Sickle cell Anemia
    • 9.3.9. Thalassemia
    • 9.3.10. Others
  • 9.4. Market Attractiveness Analysis By Indication

10. Global Bone Marrow Transplantation Market Analysis 2019-2023 and Forecast 2024-2031, by End User

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis By End User, 2019-2023
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2024-2031
    • 10.3.1. Hospitals
    • 10.3.2. Multispecialty Clinics
    • 10.3.3. Ambulatory Surgical Centers
  • 10.4. Market Attractiveness Analysis By End User

11. Global Bone Marrow Transplantation Market Analysis 2019-2023 and Forecast 2024-2031, by Region

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) Analysis By Region, 2019-2023
  • 11.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2024-2031
    • 11.3.1. North America
    • 11.3.2. Latin America
    • 11.3.3. Europe
    • 11.3.4. East Asia
    • 11.3.5. South Asia
    • 11.3.6. Oceania
    • 11.3.7. Middle East and Africa (MEA)
  • 11.4. Market Attractiveness Analysis By Region

12. North America Bone Marrow Transplantation Market Analysis 2019-2023 and Forecast 2024-2031

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 12.3.1. By Country
      • 12.3.1.1. U.S.
      • 12.3.1.2. Canada
    • 12.3.2. By Transplantation Type
    • 12.3.3. By Indication
    • 12.3.4. By End User
  • 12.4. Market Attractiveness Analysis
  • 12.5. Drivers and Restraints - Impact Analysis

13. Latin America Bone Marrow Transplantation Market Analysis 2019-2023 and Forecast 2024-2031

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 13.3.1. By Country
      • 13.3.1.1. Brazil
      • 13.3.1.2. Mexico
      • 13.3.1.3. Argentina
      • 13.3.1.4. Rest of Latin America
    • 13.3.2. By Transplantation Type
    • 13.3.3. By Indication
    • 13.3.4. By End User
  • 13.4. Market Attractiveness Analysis
  • 13.5. Drivers and Restraints - Impact Analysis

14. Europe Bone Marrow Transplantation Market Analysis 2019-2023 and Forecast 2024-2031

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 14.3.1. By Country
      • 14.3.1.1. Germany
      • 14.3.1.2. Italy
      • 14.3.1.3. France
      • 14.3.1.4. U.K.
      • 14.3.1.5. Spain
      • 14.3.1.6. Russia
      • 14.3.1.7. Rest of Europe
    • 14.3.2. By Transplantation Type
    • 14.3.3. By Indication
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
  • 14.5. Drivers and Restraints - Impact Analysis

15. South Asia Bone Marrow Transplantation Market Analysis 2019-2023 and Forecast 2024-2031

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 15.3.1. By Country
      • 15.3.1.1. India
      • 15.3.1.2. Thailand
      • 15.3.1.3. Indonesia
      • 15.3.1.4. Malaysia
      • 15.3.1.5. Rest of South Asia
    • 15.3.2. By Transplantation Type
    • 15.3.3. By Indication
    • 15.3.4. By End User
  • 15.4. Market Attractiveness Analysis
  • 15.5. Drivers and Restraints - Impact Analysis

16. East Asia Bone Marrow Transplantation Market Analysis 2019-2023 and Forecast 2024-2031

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 16.3.1. By Country
      • 16.3.1.1. China
      • 16.3.1.2. Japan
      • 16.3.1.3. South Korea
    • 16.3.2. By Transplantation Type
    • 16.3.3. By Indication
    • 16.3.4. By End User
  • 16.4. Market Attractiveness Analysis
  • 16.5. Drivers and Restraints - Impact Analysis

17. Oceania Bone Marrow Transplantation Market Analysis 2019-2023 and Forecast 2024-2031

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 17.3.1. By Country
      • 17.3.1.1. Australia
      • 17.3.1.2. New Zealand
    • 17.3.2. By Transplantation Type
    • 17.3.3. By Indication
    • 17.3.4. By End User
  • 17.4. Market Attractiveness Analysis
  • 17.5. Drivers and Restraints - Impact Analysis

18. Middle East and Africa Bone Marrow Transplantation Market Analysis 2019-2023 and Forecast 2024-2031

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 18.3.1. By Country
      • 18.3.1.1. GCC Countries
      • 18.3.1.2. Turkey
      • 18.3.1.3. South Africa
      • 18.3.1.4. Rest of Middle East and Africa
    • 18.3.2. By Transplantation Type
    • 18.3.3. By Indication
    • 18.3.4. By End User
  • 18.4. Market Attractiveness Analysis
  • 18.5. Drivers and Restraints - Impact Analysis

19. Competition Analysis

  • 19.1. Competition Dashboard
  • 19.2. Competition Deep Dive
    • 19.2.1. Lonza Group Ltd.
      • 19.2.1.1. Overview
      • 19.2.1.2. Analyst Commentary
      • 19.2.1.3. Key Financials
      • 19.2.1.4. Recent Developments
      • 19.2.1.5. Strategy Overview
    • 19.2.2. Merck Millipore Corporation
      • 19.2.2.1. Overview
      • 19.2.2.2. Analyst Commentary
      • 19.2.2.3. Key Financials
      • 19.2.2.4. Recent Developments
      • 19.2.2.5. Strategy Overview
    • 19.2.3. Sanofi-Aventis LLC.
      • 19.2.3.1. Overview
      • 19.2.3.2. Analyst Commentary
      • 19.2.3.3. Key Financials
      • 19.2.3.4. Recent Developments
      • 19.2.3.5. Strategy Overview
    • 19.2.4. STEMCELL Technologies.
      • 19.2.4.1. Overview
      • 19.2.4.2. Analyst Commentary
      • 19.2.4.3. Key Financials
      • 19.2.4.4. Recent Developments
      • 19.2.4.5. Strategy Overview
    • 19.2.5. American Type Culture Collection (ATCC) Inc
      • 19.2.5.1. Overview
      • 19.2.5.2. Analyst Commentary
      • 19.2.5.3. Key Financials
      • 19.2.5.4. Recent Developments
      • 19.2.5.5. Strategy Overview
    • 19.2.6. ReeLabs Pvt. Ltd.
      • 19.2.6.1. Overview
      • 19.2.6.2. Analyst Commentary
      • 19.2.6.3. Key Financials
      • 19.2.6.4. Recent Developments
      • 19.2.6.5. Strategy Overview
    • 19.2.7. HemaCare
      • 19.2.7.1. Overview
      • 19.2.7.2. Analyst Commentary
      • 19.2.7.3. Key Financials
      • 19.2.7.4. Recent Developments
      • 19.2.7.5. Strategy Overview

20. Assumptions and Acronyms Used

21. Research Methodology